Bringing Innovative Solutions to Healthcare Practitioners


Bringing Innovative Solutions to Healthcare Practitioners.


Bringing Innovative Solutions to Healthcare Practitioners.

A Focus on Neurology

Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide. 

Our products are developed by Moleac with scientific excellence and evidence-based approach.

Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide. 

Challenging the Boundaries to The Possible.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

Patients taking NeuroAid yearly

Awards

Countries with Exclusive Partnership

Let’s talk about moleac with noemie & david picard

Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO. 

Latest News

Nov 14 2024
News

Empowering Post-Stroke Care: Symposium Highlights with Prof. Anita Arsovska Across South Africa

We were honored to support Prof. Anita Arsovska, Vice-President of Stroke Alliance for Europe (SAFE), in conducting a series of symposiums on Advances in Post-Stroke...
Nov 12 2024
News

Uniting Minds: Advancing Stroke Recovery and Alzheimer’s Care – Highlights from Rome

Last weekend in Rome, we were honored to welcome 50 neurology experts from various countries to share experiences…

Oct 29 2024
News

Engaging Discussions at the V National Congress of Neurology in Panama: Highlights from Moleac’s NeuroAiD Symposium

Together with Droguería Saro, Moleac was honored to participate in the V National Congress of Neurology, held in Panama in October.

Oct 29 2024
News

World Stroke Day: Moleac’s Commitment to Helping Stroke Patients Reconnect with Their Lives

Today is World Stroke Day! Every year on October 29th, World Stroke Day is a great opportunity to raise awareness on stroke.

Oct 28 2024
News

Join the Upcoming ASAP Webinar on Direct Oral Anticoagulants – Supported by Moleac

Moleac is delighted to support the upcoming webinar on Direct Orals Anticoagulants hosted by the Asian Stroke Advisory Panel (ASAP) gathering neurology experts from...
Oct 25 2024
News

Reflecting on the NeuroAiD Dinner Symposium: Insights into Advancing Neurological Care at WSC 2024 in Abu Dhabi

Thank you for joining us at the NeuroAiD Dinner Symposium alongside the World Stroke Congress 2024 in Abu Dhabi.

Oct 24 2024
News

Visit Moleac at Booth 14: Explore Innovative Stroke Solutions at the World Stroke Congress in Abu Dhabi

​We are at the World Stroke Congress (WSC) in Abu Dhabi!

Oct 22 2024
News

Stepping Out for Stroke 2024: Moleac Joins SNSA Walkathon to Promote Stroke Prevention and Awareness

Moleac team was delighted to be part of the Stepping Out for Stroke 2024 walkathon, hosted by the Singapore National Stroke Association (SNSA).

Oct 22 2024
News

📢 Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia

Moleac is excited to announce a significant milestone in the journey of NeuroAiD II MLC901 as PT Ferron Par Pharmaceuticals will become our exclusive partner...
Oct 21 2024
News

Join Us at the World Stroke Congress 2024 in Abu Dhabi – Visit Us at Booth 14!

We are thrilled to announce our participation at the World Stroke Congress (WSC) from October 23ʳᵈ to 26ᵗʰ, 2024, in Abu Dhabi.